Lilly Pharma - Search News

Lilly Sues U.S. to Change Hospital Drug Discount Payments

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain hospitals.

Seeking Alpha on MSN · 7h

Eli Lilly follows JNJ in suing govt. over 340B drug-discount program

Eli Lilly (LLY) files lawsuit against U.S. health agency over 340B Program rebates, alleging arbitrary blockage of its cash replenishment model. Read more here.

Benzinga.com · 10h

Mounjaro-Maker Eli Lilly Files Lawsuit Against US Agency Over Drug Rebate Program

Eli Lilly proposed a plan to ensure 340B entities pay no more than the ceiling price by providing them with cash directly on a weekly basis.

Reuters on MSN · 14h

Lilly sues US agency over blocking of drug-rebate program

Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company's plan to change the way it offers drug discounts to hospitals. The case centers on the federal 340B program,

International Business Times · 8h

Lilly Sues US Agency For Blocking Proposed Drug Rebate Plan

Eli Lilly sued the Health Resources and Services Administration (HRSA) for allegedly blocking the pharma giant's proposal to change the manner by which it offers discounts on medicines under the 340B program.

Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

23mon MSN

U.S. Pharma is largely immune from 'MAHA' impact: Wolfe

Wolfe Research argues that despite a near-term impact, large-cap U.S. pharma stocks are largely immune from the anti-chronic ...

BioSpace6h

Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and ...

FiercePharma1d

Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

Becker's Hospital Review5h

Lilly sues feds to allow 340B changes: 5 details

Lilly filed a lawsuit Nov. 14 against HHS head Xavier Becerra and the Health Resources and Services Administration for blocking a plan to change its 340B program from immediate discounts to offering ...

Modern Healthcare4h

340B drug rebate proposal leads to another lawsuit

Eli Lilly contends it should be allowed to vet data from 340B hospitals before providing rebates, rather than offer upfront ...

STAT9d

Pharma’s ethically questionable sites essentially sell drugs directly to consumers

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

Why Eli Lilly’s CEO says failing faster is essential to the company’s success

Diane Brady: Leadership Next is powered by the folks at Deloitte who, like me, are exploring the changing roles of business ...

FiercePharma9d

After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

2don MSN

Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?

Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results